As Ontario begins the process of expanding its fourth dose vaccination program, calls are increasing to improve the distribution of Paxlovid. The antiviral medication can help a patient if it’s administered within the first five days of COVID-19 symptoms, but doctors say that’s not happening. Matthew Bingley reports.
- Lack of awareness over COVID-19 antiviral pill causing barrier to access: experts
- Ontario looking to expand distribution points for COVID-19 antiviral drug, Elliott says